Compound Detail
CHEMBL4851870
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4851870 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YLYRAJNQDKFNSB-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
358.8
MW (Da)
4.68
ALogP
5
HBA
0
HBD
43.8
PSA (Ų)
0.66
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 4.94
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 11370.0 | nM | 4.94 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 34455231 |
| B16-F10 | IC50 | = | 13340.0 | nM | 4.88 | Antiproliferative activity against mouse B16-F10 cells assessed as reduction in ... | 34455231 |
| MCF7 | IC50 | = | 14340.0 | nM | 4.84 | Antiproliferative activity against human MCF7 cells assessed as reduction in cel... | 34455231 |
| HeLa | IC50 | = | 16150.0 | nM | 4.79 | Antiproliferative activity against human HeLa cells assessed as reduction in cel... | 34455231 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34455231 | 10.1016/j.bmc.2021.116376 | B16-F10 | 1 |
| 34455231 | 10.1016/j.bmc.2021.116376 | HepG2 | 1 |
| 34455231 | 10.1016/j.bmc.2021.116376 | HeLa | 1 |
| 34455231 | 10.1016/j.bmc.2021.116376 | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine